Kelun Pharmaceutical to Use Idle Funds Worth 1.25 Billion Yuan

MT Newswires Live

Sep 05

Sichuan Kelun Pharmaceutical (SHE:002422) plans to use idle proceeds worth 1.25 billion yuan to temporarily supplement working capital for up to 12 months, according to a Shenzhen bourse filing on Friday.

The funds are part of the 2.98 billion yuan raised for 3 billion convertible bonds issued in 2022. The funds became idle after terminating certain projects where the funds were intended.

The Chinese pharmaceutical company opened special fundraising accounts at Industrial Bank (SHA:601166) and Bank of China (SHA:601988, HKG:3988) branches to regulate the management of the funds.

Changjiang Securities Underwriting and Sponsorship will designate representatives to supervise the use of the proceeds.

The company jumped over 2% during afternoon trade.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2565534145"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2565534145\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2565534145?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-05 14:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2565534145","market":"fut","top_or_hot":-1,"title":"Kelun Pharmaceutical to Use Idle Funds Worth 1.25 Billion Yuan","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/002422\">Sichuan Kelun</a> Pharmaceutical (SHE:002422) plans to use idle proceeds worth 1.25 billion yuan to temporarily supplement working capital for up to 12 months, according to a Shenzhen bourse filing on Friday.</p><p>The funds are part of the 2.98 billion yuan raised for 3 billion convertible bonds issued in 2022. The funds became idle after terminating certain projects where the funds were intended.</p><p>The Chinese pharmaceutical company opened special fundraising accounts at Industrial Bank (SHA:601166) and Bank of China (SHA:601988, HKG:3988) branches to regulate the management of the funds.</p><p><a href=\"https://laohu8.com/S/000783\">Changjiang Securities</a> Underwriting and Sponsorship will designate representatives to supervise the use of the proceeds.</p><p>The company jumped over 2% during afternoon trade.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kelun Pharmaceutical to Use Idle Funds Worth 1.25 Billion Yuan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKelun Pharmaceutical to Use Idle Funds Worth 1.25 Billion Yuan\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-09-05 14:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/002422\">Sichuan Kelun</a> Pharmaceutical (SHE:002422) plans to use idle proceeds worth 1.25 billion yuan to temporarily supplement working capital for up to 12 months, according to a Shenzhen bourse filing on Friday.</p><p>The funds are part of the 2.98 billion yuan raised for 3 billion convertible bonds issued in 2022. The funds became idle after terminating certain projects where the funds were intended.</p><p>The Chinese pharmaceutical company opened special fundraising accounts at Industrial Bank (SHA:601166) and Bank of China (SHA:601988, HKG:3988) branches to regulate the management of the funds.</p><p><a href=\"https://laohu8.com/S/000783\">Changjiang Securities</a> Underwriting and Sponsorship will designate representatives to supervise the use of the proceeds.</p><p>The company jumped over 2% during afternoon trade.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0307460666.USD","symbol_name":"EASTSPRING INVESTMENTS CHINA EQUITY \"A\" ACC","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2565534145","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2565534145","pubTimestamp":1757053211,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Sichuan Kelun Pharmaceutical  plans to use idle proceeds worth 1.25 billion yuan to temporarily supplement working capital for up to 12 months, according to a Shenzhen bourse filing on Friday.The funds are part of the 2.98 billion yuan raised for 3 billion convertible bonds issued in 2022. The funds became idle after terminating certain projects where the funds were intended.The Chinese pharmaceutical company opened special fundraising accounts at Industrial Bank  and Bank of China  branches to regulate the management of the funds.Changjiang Securities Underwriting and Sponsorship will designate representatives to supervise the use of the proceeds.The company jumped over 2% during afternoon trade.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"601166":"兴业银行","601988":"中国银行","LU0307460666.USD":"EASTSPRING INVESTMENTS CHINA EQUITY \"A\" ACC","LU2097828474.EUR":"AZ EQUITY CHINA \"A\" (EUR) ACC A","03143":"华夏香港银行股","LU2148510915.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"R\" (USD) ACC","BK1231":"综合性银行","LU0588546209.SGD":"Eastspring Investments - China Equity Fund AS SGD","BK1521":"挪威政府全球养老基金持仓","LU1634259557.SGD":"Eastspring Investments - Asian Low Volatility Equity Fund AS SGD-H","03988":"中国银行","LU1051769294.HKD":"BGF EMERGING MARKETS EQUITY INCOME \"A6\"(HKDHDG) INC","BK0060":"抗癌","LU0264606111.USD":"Janus Henderson Horizon Asian Dividend Income A2 USD","LU0293314216.USD":"ALLIANZ GEM EQUITY HIGH DIVIDEND \"A\" (USD) ACC","LU0651946864.USD":"贝莱德新兴市场股票收益A2","LU1048588211.SGD":"Blackrock Asian Dragon A2 SGD-H","LU1522347837.USD":"EASTSPRING INV ASIAN LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC A","LU1580142542.USD":"Blackrock Systematic China A-Share Opportunities A2 USD","LU1051768304.USD":"贝莱德新兴市场股票收益A6","LU1328615791.USD":"FULLERTON LUX FUNDS - ALL CHINA EQUITIES \"I\" (USD) ACC","LU1064130708.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"I\" (USD) ACC","LU1282651048.USD":"ALLIANZ GEM EQUITY HIGH DIVIDEND \"AMG\" (USD) INC","LU0348805143.USD":"ALLIANZ ENHANCED ALL CHINA EQUITY \"A\" (USD) INC","LU1515016050.SGD":"Blackrock Emerging Markets Equity Income A6 SGD-H","BK0278":"货币金融","LU1497733557.USD":"EASTSPRING INV ASIAN LOW VOLATILITY EQUITY FUND \"A\" (USD) INC A","LU1634259391.SGD":"Eastspring Investments - Asian Low Volatility Equity Fund AS SGD","IE00BWDBJ730.SGD":"Legg Mason QS - MV Asia Pacific ex Japan Equity Growth and Income A Mdis SGD-H Plus","LU1781817850.SGD":"Blackrock Systematic China A-Share Opportunities A2 SGD-H","LU0572939691.SGD":"Janus Henderson Horizon Asian Dividend Income A2 SGD","BK1560":"内银股","SG9999001093.SGD":"United Greater China Fund A Acc SGD","LU1048596156.SGD":"Blackrock Asian Growth Leaders A2 SGD-H","LU2097828714.EUR":"AZ EQUITY CHINA \"BAZ\" (EUR) ACC","BK0183":"MSCI概念","002422":"科伦药业","LU1934453819.USD":"AB CHINA A SHARES EQUITY PORTFOLIO \"A\" (USD) ACC","BK0188":"融资融券","LU0821914370.USD":"贝莱德亚洲成长领袖A2","LU2097828805.USD":"AZ EQUITY CHINA \"A-AZ\" (USD) ACC","LU1979443071.USD":"AB CHINA A SHARES EQUITY PORTFOLIO \"AD\" (USDHDG) INC","LU0572940350.SGD":"Janus Henderson Horizon Asian Dividend Income A3 SGD","LU1497733631.SGD":"Eastspring Investments - Asian Low Volatility Equity Fund ASDM SGD","LU1282651121.HKD":"ALLIANZ GEM EQUITY HIGH DIVIDEND \"AMG\" (HKD) INC","LU0651947912.USD":"BGF EMERGING MARKETS EQUITY INCOME \"A5G\" (USD) INC","BK0015":"沪股通50","BK0187":"一线龙头","LU1224444064.USD":"ALLIANZ GEM EQUITY HIGH DIVIDEND \"AM\" (USDHDG) INC","BK0028":"国家队"},"translate_title":"科伦药业将使用价值12.5亿元的闲置资金","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"601166":0.9,"601988":0.9,"002422":0.9,"03143":0.6,"03988":0.9},"content_text":"Sichuan Kelun Pharmaceutical (SHE:002422) plans to use idle proceeds worth 1.25 billion yuan to temporarily supplement working capital for up to 12 months, according to a Shenzhen bourse filing on Friday.The funds are part of the 2.98 billion yuan raised for 3 billion convertible bonds issued in 2022. The funds became idle after terminating certain projects where the funds were intended.The Chinese pharmaceutical company opened special fundraising accounts at Industrial Bank (SHA:601166) and Bank of China (SHA:601988, HKG:3988) branches to regulate the management of the funds.Changjiang Securities Underwriting and Sponsorship will designate representatives to supervise the use of the proceeds.The company jumped over 2% during afternoon trade.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}